Blackmore Capital is currently overweight the healthcare sector in our portfolios as we believe in the long-term growth outlook of the industry. Moreover, the healthcare industry is generally defensive in market downturns and was the best performer during the 2013 ‘taper tantrum’. It is a recovery play post-COVID, and we favour high-quality companies who have lagged the market. We are already seeing performance returns for defensive companies outpace cyclicals over the last quarter months as the market cycle has shown signs of slowing down.
